ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

Researchers Identify Mutation Linked to Inherited Risk of ALL

September 27, 2013

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

April 15, 1977

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

Obey Raps Reagan Administration For Blocking Report On Formaldehyde Danger

March 27, 1981

As MD Anderson Targets Eight Cancers, Detailed War Plan Remains Under Wraps

September 21, 2012

Congressional Committees Add Provisions To Cancer Act Renewal Bills To Strengthen NCI’s Independence, Prevent Fund Withholding

March 8, 1974